drugset / Trial / NCT07075237

Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

NCT07075237

Phase 4 Not yet recruiting 120 enrolled Jiangsu Province Nanjing Brain Hospital
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of Paliperidone Palmitate Injection in replacing oral antipsychotics for the treatment of schizophrenia and its impact on social function

Timeline

Start
2025-10
Primary completion
2026-10
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 75 mg Other
Subject paliperidone palmitate Unknown 150 mg Other

Indications